Global Specialty Enzymes Industry

NEW YORK, Nov. 6, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Specialty Enzymes Industry

http://www.reportlinker.com/p090599/Global-Specialty-Enzymes-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical

This report analyzes the worldwide markets for Specialty Enzymes in US$ Million by the following Product Segments: Proteases, Polymerases, Carbohydrases, and Other Specialty Enzymes. Specific end-use segments also analyzed are Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

The report profiles 43 companies including many key and niche players such as Advanced Enzymes Technologies Limited, Advanced Vital Enzymes Ltd., Amano Enzyme Inc., AST Enzymes, Biocatalysts Ltd., BBI Solutions, Chr. Hansen Holding AS, Codexis, Inc., Genzyme Corporation, Life Technologies Corporation, Meteoric Life Sciences, National Enzyme Company, ROCHE Holding, Inc., and Specialty Enzymes & Biotechnologies Co. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Product Segments I-4
Proteases I-4
Polymerases I-4
Carbohydrases I-4
Other Specialty Enzymes I-4
End-use Segments I-4
Pharmaceutical & Diagnostics I-4
Research/ Biotechnology I-4
Other End-Uses I-4

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
Specialty Enzymes: Indispensable to the Pharmaceutical Industry II-1
Outlook II-2

2. MARKET TRENDS, ISSUES AND DRIVERS II-4
Therapeutic Applications in the Pharmaceutical Industry: A
Strong Growth Driver II-4
Table 1: Global Market for Pharmaceuticals (2012): Percentage
Share Breakdown of Value Sales by Medication Class (includes
corresponding Graph/Chart) II-5
Pharmaceutical Class and Respective Growth Drivers II-5
Some Important Specialty Enzymes and their Therapeutic Areas II-6
Sources of Therapeutic Enzymes II-7
Factors Reducing the Potential of Therapeutic Enzymes II-8
Specialty Enzymes Drive down Costs in Pharmaceutical Production II-8
Focus on Preventive Medication Spurs Growth in the Diagnostic
Enzymes Market II-8
Aging Population Spurs Demand for Therapeutic and Diagnostic
Enzymes II-9
Demographic Statistics of Aging Populace: Unfurling the
Market Potential II-10
Table 2: Global Population Statistics for the 65+ Age Group:
2012 (includes corresponding Graph/Chart) II-10

Table 3: Percentage of Population Aged 65 and Above in EU-27
Countries, the US and Japan (1960-2030) 2012 (includes
corresponding Graph/Chart) II-11
Role of Specialty Enzymes in Supporting Cardiovascular Health
Boosts Market Prospects II-11
Cardiovascular Disease (CVD) Facts and Figures II-12
Robust Research Activity Bodes Well for Research and
Biotechnology Enzymes II-12
Specialty Enzyme as Biocatalysts in the Manufacture of Drugs
and Fine Chemicals Offers Significant Growth Opportunities II-13
Environment-Friendly Drug Manufacturing Processes Drive
Demand for Specialty Enzymes II-14
Advancements in Enzyme Manufacturing Processes Aids Growth II-15
Enzyme Replacement Therapies for Lysosomal Storage Diseases (
LSDs) Holds Promise II-15
Developing Countries Drives Future Market Growth II-16
Table 4: Global Value Market for Specialty Enzymes -
Geographic Regions Ranked by CAGR for 2010-2018 -
Asia-Pacific, Latin America, Rest of World, Japan, US, Canada
and Europe (includes corresponding Graph/Chart) II-17
Manufacturers in Developed Countries Move Production Base to
Developing Markets II-17
European Food Enzymes Industry Shifts Focus towards Specialty
Enzymes from Commodity Enzymes II-18
Growing Significance of Systemic Enzymes in Human Health
Strengthens Market Prospects II-19
Enzymes in Cancer Therapies Offers Immense Opportunities for
Specialty Enzymes II-19
Pain and Inflammation Management: Niche Application Area for
Specialty Enzymes II-20
Serratiopeptidase: An Agent of Inflammation Control and Pain
Management II-20
Spiraling Healthcare Costs Drives Demand for Supplemental Enzymes II-20
Advancements in Enzyme Engineering Fuels Market Growth II-21
Increasing Usage in Healthcare Facilities Bodes Well for the
Market II-22
Immobilization of Enzymes Opens up a World of Opportunities II-22
Regulatory Issues to Ensure Safety of Enzyme Usage II-23
Benefits of Enzyme Therapy II-23

3. OVERALL (INDUSTRIAL AND SPECIALTY) ENZYMES MARKET: A MACRO
PERSPECTIVE II-24
Market Drivers II-25
Major Concern II-25
Major Players II-25
Competitive Scenario II-25
Table 5: Leading Players in the Global Enzymes Market (2012):
Percentage Breakdown of Value Sales for Novozymes, Genencor,
DSM, Tier 2 Companies and Others (includes corresponding
Graph/Chart) II-25
Industrial Enzymes Market Overview II-26
Market Facts II-26
Will Growth in Europe be Held Hostage By the Debt Crisis? II-27
Optimistic Future II-28
Technological Developments Set to Drive Growth for Industrial
Enzymes II-28
Competition in the Industrial Enzymes Market II-29
Table 6: Leading Players in the Industrial Enzymes Market
(2012): Percentage Share Breakdown of Value Sales for
Novozymes, DSM, DuPont and Others (includes corresponding
Graph/Chart) II-30
Characteristics of the Industrial Enzymes Market II-30

4. PRODUCT OVERVIEW II-31
Enzymes: An Introduction II-31
A Brief History II-31
Categorization of Enzymes II-32
Advantages of Enzymes over Chemical Catalysts II-32
Classification of Enzymes Based on Application II-33
Industrial Enzymes II-33
Specialty Enzymes II-33
Proteases II-33
Polymerases II-34
Carbohydrases II-34
Other Specialty Enzymes II-35
Nucleases II-35
Lipases II-35
Catalases II-36
Oxidase II-36
Laccases II-36
Phytases II-36

5. PRODUCT INTRODUCTIONS/INNOVATIONS II-37
Enzymedica Unveils Digest Gold with ATProacents II-37
Deerland Enzymes Unveils New Enzyme-based Technologies II-37
Sekisui Enzymes Introduces New Thermostable Enzyme Range II-37
Deerland Enzymes Introduces New ThioZymeYD Dietary Supplement II-38
Sekisui Enzymes Introduces New ß-Lactamase Enzyme II-38
New England Biolabs Launches Two New DNA Polymerases II-38
Cellectis Introduces Gene-specific TAL Nucleases II-39
Eisai and Abbott Japan Introduce Lipacreon II-39
Verenium Launches Xylathin II-39
Novagen Introduces Novagen® KOD Xtreme™ Hot Start DNA
Polymerase Kit II-40

6. RECENT INDUSTRY ACTIVITY II-41
Sekisui Diagnostics Announces New Headquarters in Massachusetts II-41
Specialty Enzymes Expands Enzyme Products Manufacturing Capacity II-41
Cornerstone Therapeutics Inks Agreement with Digestive Care II-41
Codexis Extends Process and Catalyst Development Agreement
with Merck II-42
GENETRIX Inks Licensing Agreement with QIAGEN II-42
Anil Bioplus to Establish Production Unit at Halol II-42
Illumina Takes Over Epicentre Biotechnologies II-42
DSM Inks Enzyme Supply Agreement with Codexis II-43
Codexis Inks Biocatalysis Agreement With Dainippon Sumitomo
Pharma II-44
Teva Inks Licensing and Share Purchase Agreement with
Cocrystal Discovery II-44
Kilpest India, Biotools B&M Labs, and 2B Blackbio Launch 3B
BlackBio Biotech India II-44
Thermo Fisher Scientific Acquires Finnzymes II-45

7. FOCUS ON SELECT GLOBAL PLAYERS II-46
Advanced Enzymes Technologies Limited (India) II-46
Advanced Vital Enzymes Ltd. (India) II-46
Amano Enzyme, Inc. (Japan) II-47
AST Enzymes (US) II-47
Biocatalysts Ltd. (UK) II-47
BBI Solutions (UK) II-48
Chr. Hansen Holding AS (Denmark) II-48
Codexis, Inc. (US) II-48
Genzyme Corporation (US) II-49
Life Technologies Corporation (US) II-49
Meteoric Life Sciences (India) II-49
National Enzyme Company (US) II-50
ROCHE Holding, Inc. (US) II-50
Specialty Enzymes & Biotechnologies Co. (US) II-51

8. GLOBAL MARKET PERSPECTIVE II-52
Table 7: World Recent Past, Current & Future Analysis for
Specialty Enzymes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-52

Table 8: World Historic Review for Specialty Enzymes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-53

Table 9: World 15-Year Perspective for Specialty Enzymes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2004, 2013 &
2018 (includes corresponding Graph/Chart) II-54
Specialty Enzymes Market by Product Segment II-55
Table 10: World Recent Past, Current & Future Analysis for
Proteases by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-55

Table 11: World Historic Review for Proteases by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) II-56

Table 12: World 15-Year Perspective for Proteases by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2004, 2013 &
2018 (includes corresponding Graph/Chart) II-57

Table 13: World Recent Past, Current & Future Analysis for
Polymerases by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-58

Table 14: World Historic Review for Polymerases by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) II-59

Table 15: World 15-Year Perspective for Polymerases by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2004, 2013 &
2018 (includes corresponding Graph/Chart) II-60

Table 16: World Recent Past, Current & Future Analysis for
Carbohydrases by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-61

Table 17: World Historic Review for Carbohydrases by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-62

Table 18: World 15-Year Perspective for Carbohydrases by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2004, 2013 &
2018 (includes corresponding Graph/Chart) II-63

Table 19: World Recent Past, Current & Future Analysis for
Other Enzymes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-64

Table 20: World Historic Review for Other Enzymes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-65

Table 21: World 15-Year Perspective for Other Enzymes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2004, 2013 &
2018 (includes corresponding Graph/Chart) II-66
Specialty Enzymes Market by End-Use Segment II-67
Table 22: World Recent Past, Current & Future Analysis for
Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) II-67

Table 23: World Historic Review for Specialty Enzymes
Consumption in Pharmaceuticals & Diagnostics by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) II-68

Table 24: World 15-Year Perspective for Specialty Enzymes
Consumption in Medical/ Diagnostics by Geographic Region -
Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) II-69

Table 25: World Recent Past, Current & Future Analysis for
Specialty Enzymes Consumption in Research/Biotechnology by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) II-70

Table 26: World Historic Review for Specialty Enzymes
Consumption in Research/ Biotechnology by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) II-71

Table 27: World 15-Year Perspective for Specialty Enzymes
Consumption in Research/ Biotechnology by Geographic Region -
Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) II-72

Table 28: World Recent Past, Current & Future Analysis for
Specialty Enzymes Consumption in Other End-Use Segments by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) II-73

Table 29: World Historic Review for Specialty Enzymes
Consumption in Other End-Use Segments by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) II-74

Table 30: World 15-Year Perspective for Specialty Enzymes
Consumption in Other End-Use Segments by Geographic Region -
Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) II-75

III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
US Market for Specialty Enzymes - A Snapshot III-1
Specialty and Industrial Enzymes - The Difference Blurring Out III-2
Enzymes for Food Analysis and Testing - Challenges Faced III-2
Aging Population Spurs Demand for Therapeutic and Diagnostic
Enzymes III-2
Table 31: Percentage of Population Aged 65 and Above in
EU-27 Countries, the US and Japan (1960-2030) (includes
corresponding Graph/Chart) III-3
Product Launches III-3
Recent Industry Activity III-5
Key Players III-8
B.Market Analytics III-11
Table 32: US Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-11

Table 33: US Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2004 through 2009
(includes corresponding Graph/Chart) III-12

Table 34: US 15-Year Perspective for Specialty Enzymes by
Product Segment - Percentage Breakdown of Dollar Sales for
Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) III-13

Table 35: US Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-14

Table 36: US Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-15

Table 37: US 15-Year Perspective for Specialty Enzymes by
End-Use Segment - Percentage Breakdown of Dollar Sales for
Pharmaceuticals & Diagnostics, Research/Biotechnology, and
Others Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-16

2. CANADA III-17
A.Market Analysis III-17
Current and Future Analysis III-17
B.Market Analytics III-18
Table 38: Canadian Recent Past, Current & Future Analysis
for Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-18

Table 39: Canadian Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2004 through 2009
(includes corresponding Graph/Chart) III-19

Table 40: Canadian 15-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) III-20

Table 41: Canadian Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-21

Table 42: Canadian Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-22

Table 43: Canadian 15-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology,
and Others Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-23

3. JAPAN III-24
A.Market Analysis III-24
Current and Future Analysis III-24
Product Launch III-24
Recent Industry Activity III-25
Amano Enzyme, Inc. - A Japanese Key Player III-25
B.Market Analytics III-26
Table 44: Japanese Recent Past, Current & Future Analysis
for Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-26

Table 45: Japanese Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2004 through 2009
(includes corresponding Graph/Chart) III-27

Table 46: Japanese 15-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) III-28

Table 47: Japanese Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-29

Table 48: Japanese Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-30

Table 49: Japanese 15-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology,
and Others Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-31

4. EUROPE III-32
A.Market Analysis III-32
Current and Future Analysis III-32
Accelerating Trend towards Environmentally Friendly Enzymes III-32
Enzymes for Research and Biotechnology to Report Faster Gains III-32
European Food Enzymes Industry Shifts Focus towards
Specialty Enzymes from Commodity Enzymes III-33
B.Market Analytics III-34
Table 50: European Recent Past, Current & Future Analysis
for Specialty Enzymes by Geographic Region - France,
Germany, Italy, UK, Spain, Russia, and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-34

Table 51: European Historic Review for Specialty Enzymes by
Geographic Region - France, Germany, Italy, UK, Spain,
Russia, and Rest of Europe Markets Independently Analyzed
with Annual Sales Figures in US$ Thousands for Years 2004
through 2009 (includes corresponding Graph/Chart) III-35

Table 52: European 15-Year Perspective for Specialty Enzymes
by Geographic Region - Percentage Breakdown of Dollar Sales
for France, Germany, Italy, UK, Spain, Russia, and Rest of
Europe Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-36

Table 53: European Recent Past, Current & Future Analysis
for Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-37

Table 54: European Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2004 through 2009
(includes corresponding Graph/Chart) III-38

Table 55: European 15-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) III-39

Table 56: European Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-40

Table 57: European Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-41

Table 58: European 15-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology,
and Others Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-42

4a. FRANCE III-43
A.Market Analysis III-43
Current and Future Analysis III-43
Product Launch III-43
B.Market Analytics III-44
Table 59: French Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-44

Table 60: French Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2004 through 2009
(includes corresponding Graph/Chart) III-45

Table 61: French 15-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) III-46

Table 62: French Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/ Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-47

Table 63: French Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-48

Table 64: French 15-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/Biotechnology,
and Others Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-49

4b. GERMANY III-50
A.Market Analysis III-50
Current and Future Analysis III-50
B.Market Analytics III-51
Table 65: German Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-51

Table 66: German Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2004 through 2009
(includes corresponding Graph/Chart) III-52

Table 67: German 15-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) III-53

Table 68: German Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-54

Table 69: German Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-55

Table 70: German 15-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology,
and Others Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-56

4c. ITALY III-57
A.Market Analysis III-57
Current and Future Analysis III-57
B.Market Analytics III-58
Table 71: Italian Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-58

Table 72: Italian Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2004 through 2009
(includes corresponding Graph/Chart) III-59

Table 73: Italian 15-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) III-60

Table 74: Italian Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/ Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-61

Table 75: Italian Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-62

Table 76: Italian 15-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology,
and Others Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-63

4d. THE UNITED KINGDOM III-64
A.Market Analysis III-64
Current and Future Analysis III-64
Key Players III-64
B.Market Analytics III-65
Table 77: UK Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-65

Table 78: UK Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2004 through 2009
(includes corresponding Graph/Chart) III-66

Table 79: UK 15-Year Perspective for Specialty Enzymes by
Product Segment - Percentage Breakdown of Dollar Sales for
Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) III-67

Table 80: UK Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-68

Table 81: UK Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-69

Table 82: UK 15-Year Perspective for Specialty Enzymes by
End-Use Segment - Percentage Breakdown of Dollar Sales for
Pharmaceuticals & Diagnostics, Research/Biotechnology, and
Others Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-70

4e. SPAIN III-71
A.Market Analysis III-71
Current and Future Analysis III-71
Recent Industry Activity III-71
B.Market Analytics III-72
Table 83: Spanish Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-72

Table 84: Spanish Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2004 through 2009
(includes corresponding Graph/Chart) III-73

Table 85: Spanish 15-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) III-74

Table 86: Spanish Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-75

Table 87: Spanish Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-76

Table 88: Spanish 15-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology,
and Others Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-77

4f. RUSSIA III-78
A.Market Analysis III-78
Current and Future Analysis III-78
B.Market Analytics III-79
Table 89: Russian Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-79

Table 90: Russian Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2004 through 2009
(includes corresponding Graph/Chart) III-80

Table 91: Russian 15-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) III-81

Table 92: Russian Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-82

Table 93: Russian Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-83

Table 94: Russian 15-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology,
and Others Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-84

4g. REST OF EUROPE III-85
A.Market Analysis III-85
Current and Future Analysis III-85
Recent Industry Activity III-85
Chr. Hansen Holding AS (Denmark) - A Key Player III-86
B.Market Analytics III-86
Table 95: Rest of Europe Recent Past, Current & Future
Analysis for Specialty Enzymes by Product Segment -
Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-86

Table 96: Rest of Europe Historic Review for Specialty
Enzymes by Product Segment - Proteases, Polymerases,
Carbohydrases and Other Enzymes Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-87

Table 97: Rest of Europe 15-Year Perspective for Specialty
Enzymes by Product Segment - Percentage Breakdown of Dollar
Sales for Proteases, Polymerases, Carbohydrases and Other
Enzymes Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-88

Table 98: Rest of Europe Recent Past, Current & Future
Analysis for Specialty Enzymes by End-Use Segment -
Pharmaceuticals & Diagnostics, Research/ Biotechnology, and
Others Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2010 through 2018
(includes corresponding Graph/Chart) III-89

Table 99: Rest of Europe Historic Review for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/ Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-90

Table 100: Rest of Europe 15-Year Perspective for Specialty
Enzymes by End-Use Segment - Percentage Breakdown of Dollar
Sales for Pharmaceuticals & Diagnostics, Research/
Biotechnology, and Others Markets for Years 2004, 2013 &
2018 (includes corresponding Graph/Chart) III-91

5. ASIA-PACIFIC III-92
A.Market Analysis III-92
Current and Future Analysis III-92
Specialty Enzymes at Par with Industrial Enzymes in APAC III-92
Asian Countries Drives Future Market Growth III-92
Table 101: Global Value Market for Specialty Enzymes -
Geographic Regions Ranked by CAGR for 2010-2018 -
Asia-Pacific, Latin America, Rest of World, Japan, US,
Canada and Europe (includes corresponding Graph/Chart) III-93
Manufacturers in Developed Countries Move Production Base to
Developing Markets III-93
B.Market Analytics III-95
Table 102: Asia-Pacific Recent Past, Current & Future
Analysis for Specialty Enzymes by Geographic Region - China,
India, South Korea and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-95

Table 103: Asia-Pacific Historic Review for Specialty
Enzymes by Geographic Region - China, India, South Korea and
Rest of Asia-Pacific Markets Independently Analyzed with
Annual Sales Figures in US$ Thousands for Years 2004 through
2009 (includes corresponding Graph/Chart) III-96

Table 104: Asia-Pacific 15-Year Perspective for Specialty
Enzymes by Geographic Region - Percentage Breakdown of
Dollar Sales for China, India, South Korea and Rest of
Asia-Pacific Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-97

Table 105: Asia-Pacific Recent Past, Current & Future
Analysis for Specialty Enzymes by Product Segment -
Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-98

Table 106: Asia-Pacific Historic Review for Specialty
Enzymes by Product Segment - Proteases, Polymerases,
Carbohydrases and Other Enzymes Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-99

Table 107: Asia-Pacific 15-Year Perspective for Specialty
Enzymes by Product Segment - Percentage Breakdown of Dollar
Sales for Proteases, Polymerases, Carbohydrases and Other
Enzymes Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-100

Table 108: Asia-Pacific Recent Past, Current & Future
Analysis for Specialty Enzymes by End-Use Segment -
Pharmaceuticals & Diagnostics, Research/Biotechnology, and
Others Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2010 through 2018
(includes corresponding Graph/Chart) III-101

Table 109: Asia-Pacific Historic Review for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/ Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-102

Table 110: Asia-Pacific 15-Year Perspective for Specialty
Enzymes by End-Use Segment - Percentage Breakdown of Dollar
Sales for Pharmaceuticals & Diagnostics, Research/
Biotechnology, and Others Markets for Years 2004, 2013 &
2018 (includes corresponding Graph/Chart) III-103

5a. CHINA III-104
A.Market Analysis III-104
Current and Future Analysis III-104
Chinese Enzyme Demand by End-Use III-104
Table 111: Chinese Enzyme Market (2012): Percentage
Breakdown of Dollar Demand by End-Use Market - Industrial
(Food & Beverage, Cleaning Products, Animal Feed, Ethanol
Production, and Other Industrial) and Specialty (includes
corresponding Graph/Chart) III-104
Enzyme Demand by Enzyme Type III-105
Table 112: Chinese Enzyme Market (2012): Percentage
Breakdown of Dollar Demand by Enzyme Type - Carbohydrases
(Amylases and Other Carbohydrases), Proteases, Lipases,
Polymerases & Nucleases, and Other Enzymes (includes
corresponding Graph/Chart) III-105
B.Market Analytics III-106
Table 113: Chinese Recent Past, Current & Future Analysis
for Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-106

Table 114: Chinese Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2004 through 2009
(includes corresponding Graph/Chart) III-107

Table 115: Chinese 15-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) III-108

Table 116: Chinese Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/ Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-109

Table 117: Chinese Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-110

Table 118: Chinese 15-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology,
and Others Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-111

5b. INDIA III-112
A.Market Analysis III-112
Current and Future Analysis III-112
India - A Fast Growing Enzymes Market III-112
Recent Industry Activity III-112
Key Players III-113
B.Market Analytics III-115
Table 119: Indian Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-115

Table 120: Indian Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2004 through 2009
(includes corresponding Graph/Chart) III-116

Table 121: Indian 15-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) III-117

Table 122: Indian Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-118

Table 123: Indian Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics, Research/
Biotechnology, and Others Markets Independently Analyzed
with Annual Sales Figures in US$ Thousands for Years 2004
through 2009 (includes corresponding Graph/Chart) III-119

Table 124: Indian 15-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/Biotechnology,
and Others Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) III-120

5c. SOUTH KOREA III-121
A.Market Analysis III-121
Current and Future Analysis III-121
B.Market Analytics III-122
Table 125: South Korean Recent Past, Current & Future
Analysis for Specialty Enzymes by Product Segment -
Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets Independently Analyzed with Annual Sales Fig

To order this report: Global Specialty Enzymes Industry
http://www.reportlinker.com/p090599/Global-Specialty-Enzymes-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical

Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker